TCF Financial Corporation Securities Litigation

According to the Complaint, TCF Financial Corporation provides financial services through multiple channels in its primary banking markets.

See Case Details »

The Boeing Company Securities Litigation (2019)

The Complaint alleges that during the Class Period, Boeing concealed critical facts concerning the 737 MAX airplanes from investors, including the fact that Boeing designed and sold as "extras" or "optional features" safety features designed to prevent accidents such as the Lion Air and Ethiopian Airline crashes. The Complaint further alleges that Boeing also hid the fact that most airlines, including United, did not purchase these safety features. In addition, the Complaint alleges Boeing failed to disclose that Boeing had received delegated authority from the FAA over the safety analysis of the Maneuvering Characteristics Augmentation System (MCAS) – the system reportedly responsible for the crashes – that the Company delivered to the FAA, all while rushing the 737 MAX to market.

See Case Details »

The Boeing Company Securities Litigation (2019)

According to the Complaint, on March 15, 2019, Boeing filed its 2019 proxy statement (the "Proxy Statement"). The Proxy Statement seeks: (i) the election of all 13 director nominees constituting the entire Boeing board of directors (the "Board"); (ii) approval, on an advisory basis, of named executive officer compensation; (iii) ratification of the appointment of the Company's independent auditor; and (iv) certain shareholder proposals that the Board has recommended shareholders vote against, including the appointment of an independent Chairman.

See Case Details »

Coty Inc. Securities Litigation (2019)

According to the Complaint, in its SEC filings, Coty describes itself as a multi-segmented beauty company with
market positions in both North America and Europe. Coty maintains strong positions in fragrances,
professional salon hair color & styling, and color cosmetics.

See Case Details »

Amyris, Inc. Securities Litigation (2019)

According to the Complaint, Amyris purports to be an industrial biotechnology company that manufactures and
sells natural, sustainably-sourced products in health and wellness, clean beauty, and flavor and fragrance markets.

See Case Details »